Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Almeida

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Epilepsia|July 21, 2012
Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteersTeresa Nunes, José Francisco Rocha, Amílcar Falcão, et al.
Journal of Mathematical Biology|August 24, 2021
Treatment-induced shrinking of tumour aggregates: a nonlinear volume-filling chemotactic approachLuis Almeida, Gissell Estrada-Rodriguez, Lisa Oliver, et al.
Drug Metabolism Letters|July 21, 2010
Pharmacokinetics, disposition, and metabolism of [14C]-nebicapone in humansLyndon C Wright, Joana Maia, Ana I Loureiro, et al.
Journal of Biological Dynamics|May 4, 2019
Oscillatory regimes in a mosquito population model with larval feedback on egg hatchingMartin Strugarek, Laetitia Dufour, Nicolas Vauchelet, et al.
Molecular Pharmaceutics|December 16, 2014
Assessment of the amorphous "solubility" of a group of diverse drugs using new experimental and theoretical approachesLuis Almeida e Sousa, Susan M Reutzel-Edens, Gregory A Stephenson, et al.
Journal of Clinical Pharmacology|August 16, 2005
Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjectsLuis Almeida, Amílcar Falcão, Joana Maia, et al.
Biopharmaceutics & Drug Disposition|April 20, 2007
Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blockerAmílcar Falcão, Joana Maia, Luis Almeida, et al.
Journal of Theoretical Biology|July 9, 2019
A chemotaxis-based explanation of spheroid formation in 3D cultures of breast cancer cellsFederica Bubba, Camille Pouchol, Nathalie Ferrand, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 17, 2021
Clarithromycin impairs tissue-resident memory and Th17 responses to macrolide-resistant Streptococcus pneumoniae infectionsMarc Lindenberg, Luis Almeida, Ayesha Dhillon-LaBrooy, et al.
European Journal of Clinical Pharmacology|September 25, 2007
Why healthy subjects volunteer for phase I studies and how they perceive their participation?Luis Almeida, Benedita Azevedo, Teresa Nunes, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Epilepsia|July 21, 2012
Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteersTeresa Nunes, José Francisco Rocha, Amílcar Falcão, et al.
Journal of Mathematical Biology|August 24, 2021
Treatment-induced shrinking of tumour aggregates: a nonlinear volume-filling chemotactic approachLuis Almeida, Gissell Estrada-Rodriguez, Lisa Oliver, et al.
Drug Metabolism Letters|July 21, 2010
Pharmacokinetics, disposition, and metabolism of [14C]-nebicapone in humansLyndon C Wright, Joana Maia, Ana I Loureiro, et al.
Journal of Biological Dynamics|May 4, 2019
Oscillatory regimes in a mosquito population model with larval feedback on egg hatchingMartin Strugarek, Laetitia Dufour, Nicolas Vauchelet, et al.
Molecular Pharmaceutics|December 16, 2014
Assessment of the amorphous "solubility" of a group of diverse drugs using new experimental and theoretical approachesLuis Almeida e Sousa, Susan M Reutzel-Edens, Gregory A Stephenson, et al.
Journal of Clinical Pharmacology|August 16, 2005
Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjectsLuis Almeida, Amílcar Falcão, Joana Maia, et al.
Biopharmaceutics & Drug Disposition|April 20, 2007
Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blockerAmílcar Falcão, Joana Maia, Luis Almeida, et al.
Journal of Theoretical Biology|July 9, 2019
A chemotaxis-based explanation of spheroid formation in 3D cultures of breast cancer cellsFederica Bubba, Camille Pouchol, Nathalie Ferrand, et al.
Journal of Molecular Medicine (Berlin, Germany)|February 17, 2021
Clarithromycin impairs tissue-resident memory and Th17 responses to macrolide-resistant Streptococcus pneumoniae infectionsMarc Lindenberg, Luis Almeida, Ayesha Dhillon-LaBrooy, et al.
European Journal of Clinical Pharmacology|September 25, 2007
Why healthy subjects volunteer for phase I studies and how they perceive their participation?Luis Almeida, Benedita Azevedo, Teresa Nunes, et al.
Pageof 14